Your browser doesn't support javascript.
loading
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Du, Xin; Chen, Chun-Yan; Weng, Jian-Yu; Huang, Jian; Li, Fei; Zeng, Yun; Xiao, Zhen; Hu, Jian-da; Yang, Li-Jie; Liu, Zhuo-Gang; Li, Guo-Hui; Sun, Xiu-Li; Yang, Wei; Feng, Ru; Han, Yan-Qiu; Jing, Yu; Xu, Na; Liu, Xiao-Li; Liu, Zhen-Fang; Wang, Xiao-Dong; Wu, Shi-Xin; Liang, Rong; Zhang, Yan-Li; Yang, Yun-Fan; Zhu, Huan-Ling; Pan, Ling; Meng, Li; Zhao, Yan-Hong; Yi, Hai; Liu, Yi-Lan; Zhang, Wei-Hua; Zheng, Yuan-Jun; Zhou, Ze-Ping; Chen, Su-Ning; Qiu, Hui-Ying; Li, Wei-Ming; Jia, Zhi-Lin; Bai, Yan-Liang; Lin, Li-E; Liu, Bing-Cheng; Liu, Chun-Shui; Luo, Jian-Min; Meng, Jun-Xia; Sun, Zhi-Qiang; Zhang, Yan-Qing; Huang, Xiao-Jun; Jiang, Qian.
Afiliação
  • Yang S; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Zhang X; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.
  • Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK.
  • Du X; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Chen CY; Department of Haematology, Qilu Hospital, Shandong University, Jinan, China.
  • Weng JY; Department of Haematology, Guangdong Provincial People's Hospital, Guangzhou, China.
  • Huang J; Department of Haematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China.
  • Li F; Department of Haematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Zeng Y; Center of Haematology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Xiao Z; The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Hu JD; The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.
  • Yang LJ; Fujian Medical University Union Hospital, Fuzhou, China.
  • Liu ZG; Xi'an International Medical Center Hospital, Xi'an, China.
  • Li GH; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Sun XL; Xi'an International Medical Center Hospital, Xi'an, China.
  • Yang W; Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Feng R; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Han YQ; Department of Hematology, Beijing Hospital, Beijing, China.
  • Jing Y; The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China.
  • Xu N; Department of Hematology, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Liu XL; Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu ZF; Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang XD; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Wu SX; Department of Haematology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Liang R; Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China.
  • Zhang YL; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
  • Yang YF; The Second Affiliated Hospital of Fujian Medical University, Fujian, China.
  • Zhu HL; Department of Haematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Pan L; Department of Haematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Meng L; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China.
  • Zhao YH; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China.
  • Yi H; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China.
  • Liu YL; Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang WH; The First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Zheng YJ; Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China.
  • Zhou ZP; Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China.
  • Chen SN; First Hospital of Shangxi Medical University, Shangxi, China.
  • Qiu HY; First Hospital of Shangxi Medical University, Shangxi, China.
  • Li WM; Dept. of Hematology, The Second Hospital Affiliated to Kunming medical university, Kunming, China.
  • Jia ZL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
  • Bai YL; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China.
  • Lin LE; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu BC; Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Liu CS; Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
  • Luo JM; Hainan General Hospital, Hainan, China.
  • Meng JX; National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Sun ZQ; First Hospital of Jilin University, Jilin, China.
  • Zhang YQ; The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Huang XJ; Anyang District Hospital, Puyang, China.
  • Jiang Q; Shenzhen Hospital of Southern Medical University, Shenzhen, China.
Am J Hematol ; 98(7): E183-E186, 2023 07.
Article em En | MEDLINE | ID: mdl-37128776
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos